Abiopharma

🔍 SANDERS MACHELLE (Director)

Company: BIOCRYST PHARMACEUTICALS INC (BCRX)

Report Date: 2026-06-11

Detailed Transactions and Holdings:

• Acquired 15,294 shares of Common Stock (Direct)
  Date: 2026-06-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 45,936.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 33,540 shares of Automatic Stock Option Grant at $8.5 per share (Derivative)
  Date: 2026-06-11 | Code: A | Expires: 2036-06-11 | Exercise: 2027-06-11 | equity_swap_involved: 0 | shares_owned_after: 33,540.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
• F2: Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.